RSS

BioNTech

MAB Discovery has entered into a second collaboration agreement with European biopharmaceutical company, BioNTech, which will see MAB Discovery’s technology platform applied to proprietary targets provided by BioNTech. more

Technology

BioNTech is a biotech company specialising in lab-to-market immunotherapies. Sean Marett, COO reveals the reasons for his love of biotech and the company’s quest to further advances in this field more

Opinion

A clinically applicable mRNA cancer immunotherapy vaccine has been developed by BioNTech, a biotechnology company developing individualised cancer immunotherapies and TRON, the translational oncology department at the Johannes Gutenberg University more

News

Bayer and Biontech, a immunotherapy company headquartered in Mainz have entered into an agreement to develop novel, first-in-class mRNA vaccines and therapeutics specifically for animal health applications. more

News

Sanofi and BioNTech have entered into a research collaboration and license agreement to develop up to five cancer immunotherapies more

News

As October is Breast Cancer Awareness month EPM has put together a list of medical developments and partnerships in the pharmaceutical sector that are helping to treat cancer more

Opinion

BioNTech RNA Pharmaceuticals and EUFETS will work with Siemens to produce a fully automated and digitalised production site, providing capacity for BioNTech’s personalised cancer vaccines to serve worldwide markets. more

News

BioNTech has announced the launch of its MammaTyper, a CE-IVD marked molecular diagnostic test to stratify breast cancer patients by molecular subtyping of routine tumour tissue. more

News

BioNTech and Genmab have collaborated to research, devlop and commercialise multiple bispecific antibodies for cancer immunotherapy. more

News